Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wärtsilä Testing Update

3 Mar 2023 07:00

RNS Number : 7432R
Quadrise Fuels International PLC
03 March 2023
 

3 March 2023

Quadrise Fuels International Plc ("Quadrise" or the "Company")

Wärtsilä Testing Update

Quadrise Fuels International Plc (AIM:QFI), the supplier of innovative energy solutions for a cleaner planet, provides the following update further to the Company's announcement of 16 January 2023, on the testing of its bioMSAR™ fuel carried out by Wärtsilä Services Switzerland ("Wärtsilä") in December 2022.

As part of Quadrise's ongoing Framework Agreement with MSC Shipmanagement, optical combustion and engine wear tests of bioMSAR™ were carried out as a necessary precursor to commercial-scale vessel trials.

The optical combustion test, against MSAR® and diesel fuels, has confirmed bioMSAR™ to have similar injection and combustion properties as MSAR® and that bioMSAR™ is therefore expected to behave similarly to MSAR® when utilised in medium and slow-speed diesel engines.

Extended wear tests over a 250 hour period were also completed successfully. 

The Company is pleased to confirm that, as a result of these test results, bioMSAR™ can proceed to the next phase of assessment, with hazard identification and operability studies now scheduled ahead of commercial vessel testing on the MSC Leandra and further announcements will be made, as appropriate, in due course.

Jason Miles, Chief Executive of Quadrise, commented:

 

"The extensive tests undertaken by Wärtsilä clearly demonstrate the suitability of bioMSAR™ for use in both marine and power plant applications. This is an important step in clearing the fuel for commercial supply and we look forward to progressing our final round of tests ahead of planned vessel trials with MSC for both MSAR® and bioMSAR™ later this year."

 

For additional information, please contact:

 

Quadrise Fuels International Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

Nominated Adviser

Cenkos Securities plc

+44 (0)20 7397 8900

Ben Jeynes

Katy Birkin

Broker

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs, Rachel Goldstein (Corporate Advisory)

Fiona Conroy (Corporate Broking)

Public & Investor Relations

 

 

Vigo Consulting

Patrick D'Ancona

Charlie Neish

+44 (0)20 7390 0230

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to reduce energy costs and greenhouse gas emissions today for clients in the global power generation, shipping, industrial and refining industries.

Learn more: www.quadrisefuels.com

 

Certain of the information contained within this announcement is deemed by the Company to constitute inside information as stipulated under The Market Abuse Regulation (EU 596/2014) pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2018. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSSIEFEEDSESD
Date   Source Headline
7th Oct 20197:00 amRNSFinal Results for the year ended 30 June 2019
2nd Oct 201911:42 amRNSTotal Voting Rights
30th Sep 20197:18 amRNSResult of Open Offer
27th Sep 20194:09 pmRNSIssue of Warrants
27th Sep 20192:03 pmRNSResult of General Meeting
9th Sep 20197:00 amRNSOpen Offer, Subscription and Notice of GM
6th Sep 20193:00 pmRNSWebsite Update
30th Aug 20195:07 pmRNSIssue of Convertible Security
27th Aug 20197:00 amRNSInvestor Conference Call
23rd Aug 20197:00 amRNSConvertible Securities, Issue of Equity & Warrants
19th Aug 20197:00 amRNSFunding Update
14th Aug 20197:00 amRNSMOU with Merlin Energy Resources Ltd
12th Aug 20194:40 pmRNSSecond Price Monitoring Extn
12th Aug 20194:36 pmRNSPrice Monitoring Extension
12th Aug 201912:02 pmRNSPrice Monitoring Extension
12th Aug 20197:00 amRNSMemorandum of Agreement with European Oil Refiner
23rd Jul 201911:08 amRNSStmnt re Share Price Movement
10th Jul 20197:00 amRNSDirector/PDMR Shareholding
3rd Jul 20197:00 amRNSPDMR Shareholding and Transfer of Share Options
27th Jun 20195:20 pmRNSIssue of Share Options
24th Jun 20194:40 pmRNSSecond Price Monitoring Extn
24th Jun 20194:35 pmRNSPrice Monitoring Extension
24th Jun 201911:41 amRNSAppointment of Joint Broker
13th Jun 20197:00 amRNSKSA Services Agreement and Grant of Warrants
11th Jun 20197:00 amRNSAgency Agreement for Mexico
30th May 20198:59 amRNSReplacement: MOA with Al Khafrah Holding Group
30th May 20197:00 amRNSMOU with Al Khafrah Holding Group
20th May 20193:00 pmRNSUpdate on Test Programme and Termination of MOA
15th May 20197:00 amRNSInvestor Conference Call
13th May 20197:00 amRNSMOU with API POLY-GCL Alliance
8th May 20193:23 pmRNSHolding(s) in Company
8th May 20197:00 amRNSKuwait Agency Agreement and MoU
23rd Apr 201911:40 amRNSDirectorate Change
27th Mar 20197:00 amRNSMemorandum of Understanding with Bitumina
25th Mar 20197:00 amRNSHalf-year Report
18th Mar 20194:40 pmRNSSecond Price Monitoring Extn
18th Mar 20194:35 pmRNSPrice Monitoring Extension
6th Mar 20197:00 amRNSRepresentation Agreement and Grant of Warrants
26th Feb 20197:00 amRNSKuwait Services Agreement & Grant of Warrants
13th Feb 20197:00 amRNSInvestor Site Visit
31st Jan 201912:00 pmRNSTotal Voting Rights
21st Jan 20197:00 amRNSResult of Open Offer
7th Jan 20195:11 pmRNSExtension of Open Offer Closing Date
12th Dec 20187:01 amRNSInvestor Conference Call
12th Dec 20187:00 amRNSChange of Adviser
7th Dec 20187:00 amRNSOpen Offer
30th Nov 20184:07 pmRNSResult of AGM
30th Nov 20187:00 amRNSCo-Marketing & Project Development Agreement
28th Nov 20187:00 amRNSMOU and MSAR® Test Programme
26th Nov 20187:00 amRNSExtension of Contracts with AkzoNobel

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.